Regarding the latter resolution, this paper introduced the use of GLP-1RAsa drug class traditionally used in the treatment and management of T2DM and obesityas a potential avenue for the treatment of neurodegenerative diseases and neuropathologic conditions alike due to the drugs extensively cited neuroprotective effects
Its not just weight loss, Gaba says
Its not hard to understand why sticking with this regime is challenging a large minority of patients report unpleasant side effects such as nausea and vomiting, and some experience additional side effects such as injection-site reactions, infections, heart burn, and headaches
Many GLP-1 promotions target women who are not medically obese or diabetic
In the trial, people on the Wegovy pill lost about 13.6% of their body weight, while people on a placebo lost about 2% after 71 weeks
Always discuss costs and coverage with your provider upfront